Grand Medical Group

About us

Grand Medical Group AG is a group of pharmaceutical companies specialized in the development, production, registration and introduction into medical practice of modern innovative products based on organic, synthetic and herbal compounds.

read more

10 Kornmarkt Street, CH - 6004 Luzern, Switzerland

info@grandmedicalgroup.ch

+41 415880810

Each tablet contains 20mg tenoxicam, ? 10 Each vial contains 20mg tenoxicam as lyophilized sterile powder for reconstitution, vial ?1

PHARMACOLOGIC PROPERTIES

ATC code: M01AC02, Antirheumatic, anti-in?ammatory and analgesic agent Tenoxicam is a non-steroidal anti-in?ammatory drug (NSAID) which has anti-in?ammatory, analgesic, antipyretic properties and it also inhibits platelet aggregation. Tenoxicam reduces prostaglandin biosynthesis by inhibition of cyclooxygenase 1 (COX1) and 2 (COX2), both in vitro and in vivo. Tenoxicam is a potent in-vitro inhibitor of human metalloproteinases (stromelysin and collagenase) which induce cartilage breakdown.

THERAPEUTIC INDICATIONS

OXITEN is indicated for the relief of pain and in?ammation in osteoarthritis and rheumatoid arthritis. It is also indicated for the short term management of acute musculoskeletal disorders including strains, sprains and other soft-tissue injuries. IV, IM tenoxicam is also available for these indications in those patients considered unable to take oral tenoxicam.

LEAFLETS